Chemed Co. (CHE) Insider Spencer S. Lee Sells 669 Shares of Stock

Chemed Co. (NYSE:CHE) insider Spencer S. Lee sold 669 shares of the company’s stock in a transaction that occurred on Friday, November 30th. The stock was sold at an average price of $314.76, for a total transaction of $210,574.44. Following the sale, the insider now directly owns 30,589 shares in the company, valued at approximately $9,628,193.64. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

CHE stock traded up $4.63 during midday trading on Friday, reaching $316.78. The company had a trading volume of 132,160 shares, compared to its average volume of 104,490. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.14 and a quick ratio of 1.11. Chemed Co. has a 1 year low of $234.00 and a 1 year high of $335.99. The stock has a market cap of $5.00 billion, a PE ratio of 59.10, a P/E/G ratio of 2.74 and a beta of 1.23.

Chemed (NYSE:CHE) last released its quarterly earnings results on Monday, October 29th. The company reported $3.07 EPS for the quarter, topping the Zacks’ consensus estimate of $2.80 by $0.27. Chemed had a net margin of 11.73% and a return on equity of 35.13%. The business had revenue of $444.15 million during the quarter, compared to analysts’ expectations of $445.16 million. During the same quarter in the previous year, the company earned $2.15 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, research analysts expect that Chemed Co. will post 11.41 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, December 3rd. Shareholders of record on Monday, November 12th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.20 dividend on an annualized basis and a yield of 0.38%. Chemed’s dividend payout ratio is presently 22.39%.

A number of hedge funds have recently added to or reduced their stakes in the business. Fort L.P. purchased a new stake in shares of Chemed in the 2nd quarter valued at $120,000. Cerebellum GP LLC purchased a new stake in shares of Chemed in the 3rd quarter valued at $148,000. Tower Research Capital LLC TRC boosted its stake in shares of Chemed by 70.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 544 shares of the company’s stock valued at $175,000 after purchasing an additional 224 shares in the last quarter. Franklin Resources Inc. purchased a new stake in shares of Chemed in the 3rd quarter valued at $225,000. Finally, We Are One Seven LLC purchased a new stake in shares of Chemed in the 3rd quarter valued at $228,000. 90.15% of the stock is owned by institutional investors and hedge funds.

A number of analysts recently weighed in on the stock. Zacks Investment Research reaffirmed a “buy” rating and set a $342.00 target price on shares of Chemed in a report on Monday, November 12th. Bank of America assumed coverage on shares of Chemed in a report on Friday, October 12th. They set a “buy” rating and a $390.00 target price on the stock. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Chemed presently has an average rating of “Buy” and a consensus target price of $332.00.

ILLEGAL ACTIVITY WARNING: “Chemed Co. (CHE) Insider Spencer S. Lee Sells 669 Shares of Stock” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Further Reading: Understanding Market Liquidity

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit